Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEPATOTRAS HBV revaccination trial in cirrhotic liver transplant candidates
2011-005372-42Phase 3Active
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Recombivax HB in hepatitis B (HBV) (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Post-vaccination serological response. Started Jan 2012; status: active.
02
Drugs
Recombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2011-005372-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005372-42.